itsnew.Best
photo profile itsnew.Best 847 Posts
statut itsnew.Best Certified
Biography
Business | Innovation
Inspiration | Motivation
About Science Insider
image  1 Science Insider - A clinical trial of a new Alzheimer’s drug from Japanese pharmaceutical company Ei
Share
September 28, 2022

A clinical trial of a new Alzheimer’s drug from Japanese pharmaceutical company Eisai and Biogen has shown promising results. The large-scale study saw cognitive decline in patients being slowed by 27% over 18 months. The trial involved 1,795 patients with early-stage Alzheimer’s. Their cognitive decline was measured on six fronts, including “memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care.”According to the statement, lecanemab significantly “reduced clinical decline” over the 18-month timeframe.Read more at the link in our bio. Story by Cheryl Teh.(Credit: DBenitostock)
#itsnew #bestitsnew #scienceinsider